|
Anti-platelet agents |
Bridging therapy |
Anti-platelet /anticoagulant drugs |
C1 |
withhold for 7d |
LMWH** |
LMWH POD1-6**, ASA+clopidogrel POD7 to
discharge* |
C2 |
ASA+clopidogrel* |
none |
ASA+clopidogrel POD1 to
discharge* |
C3 |
withhold for 8d |
LMWH** |
ASA+clopidogrel POD1 to
discharge* |
C4 |
withhold for 8d |
LMWH** |
ASA+clopidogrel POD1-3; withhold POD
4-7; resume POD8 to discharge* |
C5 |
withhold for 7d |
LMWH** |
LMWH POD1-6**, ASA+clopidogrel POD7 to
discharge* |